Maha Al draimly
King Saud University, Saudi Arabia
Title: Impact of clinical pharmacist counselling on disease outcome parameters and quality of life on uncontrolled hypertensive diabetic dyslipidemia
Biography
Biography: Maha Al draimly
Abstract
Hypertension and dyslipidemia are main complications of diabetes. Hypertension prevalence 28.7% in US, Diabetes prevalence 7%, while prevalence of diabetes in SA is 27% and HTN is 26%. Clincal pharmacist is health science discipline in which pharmacist provide patient care that optimizes medication therapy and promotes health, wellness and disease prevention. Intervention of clinical pharmacist with Family medicine physician in managing and education of uncontrolled hypertensive, diabetic, dyslipidemic patients is expected to improve compliance with drug therapy, chronic disease outcome parameters and patient quality of life. 300 patients of uncontrolled hypertensive, diabetic and dyslipidemic are enrolled in this observational cohort study held in 3 ambulatory care centers at King Abdulaziz Medical city in Riyadh, 200 patients as sample, 100 as control. Quality of life measured at the base line and at the end of study for sample patients. Hba1c measured for each patients with BP and LDL with follow up with clinical pharmacist every 3 to 4 month for 5 visits, during this visit clinical pharmacist revise all of lab parameters for patients with medications file, doing education for patients, after finishing all visits of patients BP, Hba1c and LDl will be measured to measure the outcome and improvement of quality of life, to show the effect of clinical pharmacist intervention and education on upper parameters.